Tech Company Financing Transactions
Genocea Biosciences Funding Round
Polaris Partners participated in a $1.8 million capital raise for Genocea Biosciences. The financing round was recorded on 6/30/2013.
Transaction Overview
Company Name
Announced On
6/30/2013
Transaction Type
Venture Equity
Amount
$1,762,000
Round
Undisclosed
Investors
Polaris Partners (Kevin Bitterman)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Acorn Park Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chip Clark
Chief Financial Officer
Diantha Duvall
Chief Medical Officer
Thomas Davis
Chief Scientific Officer
Jessica Flechtner
VP - Bus. Development
Girish Aakalu
VP - Manufacturing
Narinder Singh
Browse more venture capital transactions:
Prev: 6/30/2013: Pickwick & Weller venture capital transaction
Next: 6/30/2013: Ohanae venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs